Skip to main content
Cenobamate gains FDA approval for partial-onset seizures in adults with epilepsy

A new therapy was approved by the FDA on Thursday as a treatment for the partial onset of epileptic seizures in adults. Xcopri, or cenobamate, will be marketed by SK Life Science and will be launched by the second quarter of 2020.

Full Story: